In the race to deploy artificial intelligence in medicine, China has surged ahead of the U.S. and other countries, spawning technology companies that are using algorithms and novel software tools to help treat millions of patients and relieve pressure on the country’s overwhelmed hospital system.

One company, WeDoctor, uses a combination of AI and telemedicine to conduct 90,000 online consultations a day and screen patients for cancer and chronic diseases. No company with anywhere near such reach exists in the U.S.

Unlock this article by subscribing to STAT Plus and enjoy your first 30 days free!

GET STARTED

What is it?

STAT Plus is a premium subscription that delivers daily market-moving biopharma coverage and in-depth science reporting from a team with decades of industry experience.

What's included?

  • Authoritative biopharma coverage and analysis, interviews with industry pioneers, policy analysis, and first looks at cutting edge laboratories and early stage research
  • Subscriber-only networking events and panel discussions across the country
  • Monthly subscriber-only live chats with our reporters and experts in the field
  • Discounted tickets to industry events and early-bird access to industry reports

Sign up for our Daily Recap newsletter

A roundup of STAT’s top stories of the day in science and medicine

Privacy Policy